FBN’s Charles Payne, NewOak Capital President James Frischling, small business expert Susan Solovic, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the outlook for Cubist Pharmaceuticals.
American Cancer Society’s Dr. Len Lichtenfeld on the pricey new cancer medications going on sale.
Stossel and his family members talk about out-of-the-ordinary things they've tried
NYU Langone Medical Center’s Dr. Natalie Azar on the Ebola outbreak in Africa.
F5 Networks CEO John McAdam explains why company shares are continuing to rise and how the company protects data.
Former federal prosecutor Doug Burns on the DOJ’s indictment of FedEx over prescription drug shipments.
‘Unstoppable’ author Ralph Nader on the mounting General Motors recall scandal.
FBN’s Liz MacDonald on companies with massive overseas cash piles.
The Goldwater Institute’s Lucy Caldwell on the ‘Right to Try’ legislation.
MDC Partners CEO Miles Nadal on the collapse of the Omnicom-Publicis deal.
Schaefer’s Investment Research senior equity analyst Joe Bell and Bryn Mawr Trust CIO Ernie Cecilia on LinkedIn and other stocks to invest in.
Stossel and guest discuss how government uses its force to push people around and take their stuff
FNC Medical A-Team’s Dr. Marc Siegel on the MRSA Superbug, Ebola and a second wave of the Flu hitting the Northeastern U.S.
Stanford University Fellow Vivek Wadhwa on how the tech industry will impact health care.
HealthGrades.com Strategic Advisor Dr. Archelle Georgiou on helping consumers finding the right doctors and hospitals.
Black Rock Group Senior Director Lisa Boothe and Newsday columnist Ellis Henican on efforts to contain the Ebola crisis.
FBN’s Tom Sullivan and Charlie Gasparino on the threat of Ebola coming to the U.S. and travel bans.
Radiation oncologist Dr. Elizabeth Chabner Thompson on the high price tags in the fight against cancer.
FBN’s Charles Payne, Lebenthal Asset Management’s James Lebenthal and Penn Financial Group founder Matt McCall on the outlook for Medivation.
Fox News Medical A-Team's Dr. Marc Siegel discusses a new drug to treat breast cancer.